ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p830.xmlEsophageal and Esophagogastric Junction Cancers2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p830.pdf2026-04-18Esophageal and Esophagogastric Junction Cancershttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p815.xmlDrug Shortages: Impact and Strategies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p815.pdf2026-04-18Drug Shortages: Impact and Strategieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p811.xmlCrescendos and Decrescendos: Gastric and Esophageal Cancers2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p811.pdf2026-04-18Crescendos and Decrescendos: Gastric and Esophageal Cancershttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-pxix.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-pxix.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-pxxx.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-pxxx.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p821.xmlProton Therapy in an Era of Cost Containment2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p821.pdf2026-04-18Proton Therapy in an Era of Cost Containmenthttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p914.xmlMyeloid Growth Factors2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p914.pdf2026-04-18Myeloid Growth Factorshttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p902.xmlModern Approaches to Localized Cancer of the Esophagus2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p902.pdf2026-04-18Modern Approaches to Localized Cancer of the Esophagushttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p934.xmlBiosimilars: Are They Ready for Primetime in the United States?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p934.pdf2026-04-18Biosimilars: Are They Ready for Primetime in the United States?https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p945.xmlLong-Term Outcomes of Myeloid Growth Factor Treatment2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p945.pdf2026-04-18Long-Term Outcomes of Myeloid Growth Factor Treatmenthttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p890.xmlEndoscopic Therapy of Esophageal Premalignancy and Early Malignancy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/8/article-p890.pdf2026-04-18Endoscopic Therapy of Esophageal Premalignancy and Early Malignancy